Victor Dzau Leaving Duke To Head The Institute Of Medicine

Really don’t miss this critical update: Newly Elected President Of Institute of Medicine Is On The Pepsico Board Of Directors 

Cardiologist Victor Dzau will depart his positions as the chancellor for health affairs at Duke University and the CEO of the Duke University Wellness Method to turn into the next president of the Institute of Medication. He will replace Harvey Fineberg, who has been the IOM president for the last 12 years.

“I am humbled and honored to be picked to lead the IOM at a time of unprecedented opportunities and issues in health, well being care, and biomedical sciences,” said Dzau in a statement from the IOM. “Harvey Fineberg has been an outstanding leader of the IOM, and I am committed to creating on his outstanding perform and advancing the impact of the IOM on the nation and globally.”

Before moving to Duke almost a decade in the past Dzau was the chair of the department of medicine and director of analysis at Brigham and Women’s Hospital and the Hersey Professor of the Concept and Practice of Physic (Medicine) at Harvard Medical College. Prior to that he had been the chair of the department of medicine at Stanford University. In his job as a researcher Dzau played a essential role in comprehending the renin-angiotensin-aldosterone program.

Robert Califf, director of the Duke Translational Medication Institute, sent the following comment:

This appointment is a genuine honor for Victor and for Duke. In the course of his tenure, the instituiton has grown into an academic wellness and science method, created numerous scientific contributions and thrived financially.

Dzau was initial elected to the IOM in 1998. He will get started his 6-12 months term as president on July 1.

Victor Dzau Leaving Duke To Head The Institute Of Medicine